Bipolar disorders

RS McIntyre, M Berk, E Brietzke, BI Goldstein… - The Lancet, 2020 - thelancet.com
Bipolar disorders are a complex group of severe and chronic disorders that includes bipolar
I disorder, defined by the presence of a syndromal, manic episode, and bipolar II disorder …

Bipolar disorders

E Vieta, M Berk, TG Schulze, AF Carvalho… - Nature reviews Disease …, 2018 - nature.com
Bipolar disorders are chronic and recurrent disorders that affect> 1% of the global
population. Bipolar disorders are leading causes of disability in young people as they can …

The 2020 Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders

GS Malhi, E Bell, D Bassett, P Boyce… - Australian & New …, 2021 - journals.sagepub.com
Objectives: To provide advice and guidance regarding the management of mood disorders,
derived from scientific evidence and supplemented by expert clinical consensus to formulate …

[HTML][HTML] KDIGO 2024 Clinical practice guideline for the evaluation and management of chronic kidney disease

PE Stevens, SB Ahmed, JJ Carrero… - Kidney …, 2024 - kidney-international.org
This article is published as part of a supplement sponsored by Kidney Disease: Improving
Global Outcomes (KDIGO). The opinions or views expressed in this supplement are those of …

Adjunctive psychotherapy for bipolar disorder: a systematic review and component network meta-analysis

DJ Miklowitz, O Efthimiou, TA Furukawa, J Scott… - JAMA …, 2021 - jamanetwork.com
Importance Several psychotherapy protocols have been evaluated as adjuncts to
pharmacotherapy for patients with bipolar disorder, but little is known about their …

Safety, tolerability, and risks associated with first-and second-generation antipsychotics: a state-of-the-art clinical review

M Solmi, A Murru, I Pacchiarotti… - … and clinical risk …, 2017 - Taylor & Francis
Since the discovery of chlorpromazine (CPZ) in 1952, first-generation antipsychotics (FGAs)
have revolutionized psychiatric care in terms of facilitating discharge from hospital and …

[HTML][HTML] The dopamine hypothesis of bipolar affective disorder: the state of the art and implications for treatment

AH Ashok, TR Marques, S Jauhar, MM Nour… - Molecular …, 2017 - nature.com
Bipolar affective disorder is a common neuropsychiatric disorder. Although its
neurobiological underpinnings are incompletely understood, the dopamine hypothesis has …

Evidence-based consensus guidelines for the management of catatonia: Recommendations from the British Association for Psychopharmacology

JP Rogers, MA Oldham, G Fricchione… - Journal of …, 2023 - journals.sagepub.com
The British Association for Psychopharmacology developed an evidence-based consensus
guideline on the management of catatonia. A group of international experts from a wide …

[HTML][HTML] Pharmacological treatment for bipolar mania: a systematic review and network meta-analysis of double-blind randomized controlled trials

T Kishi, T Ikuta, Y Matsuda, K Sakuma, M Okuya… - Molecular …, 2022 - nature.com
A systematic review and random-effects model network meta-analysis was conducted to
compare the efficacy, acceptability, tolerability, and safety of pharmacological interventions …

Minocycline and celecoxib as adjunctive treatments for bipolar depression: a multicentre, factorial design randomised controlled trial

MI Husain, IB Chaudhry, AB Khoso, MO Husain… - The Lancet …, 2020 - thelancet.com
Background Several small studies suggest that the adjunctive use of anti-inflammatory
agents might improve depressive symptoms in bipolar disorder. However, there are few well …